<DOC>
	<DOC>NCT00794170</DOC>
	<brief_summary>Study participants who receive the I-SIGHT intervention will have higher rates of glaucoma treatment compliance (e.g., medication-taking and refill compliance, return for clinical follow-up) and more positive eye health outcomes at 12-month follow-up than participants who receive the control group intervention.</brief_summary>
	<brief_title>Interactive Study to Increase Glaucoma Adherence to Treatment</brief_title>
	<detailed_description>The intervention is telephone-based and individually-tailored to participants' compliance knowledge, attitudes, and behaviors; psychosocial predictors of compliance; health literacy; race and culture; and prescribed medication regimen. The intervention calls utilize interactive voice recognition technology to facilitate interest, participation, and interaction with call recipients. We evaluated the intervention in a randomized controlled trial with telephone interviews administered to all participants at baseline, 6, 9, and 12-months</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Receive treatment at the Atlanta VA Medical Center or Grady Eye clinic for their eye condition Be between the ages of 1880 Be Caucasian or African American Possess a telephone (home telephone or cellular phone) Speak and understand English Be diagnosed with open angle glaucoma, be glaucoma suspect, or be ocular hypertensive for at least one year Be prescribed daily doses of topical treatments for at least one year Be able to read or have someone who can help the participant with reading written materials that we give to the participant Having eye surgery within 3 months of baseline interview and enrollment Being legally blind (20/200 or worse)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Treatment Compliance</keyword>
</DOC>